期刊文献+

烟雾病患者血流动力学及血清中VEGF、MCP-1水平变化

Changes of Hemodynamics and Serum VEGF and MCP-1 Levels in Patients with Moyamoya Disease
下载PDF
导出
摘要 目的探讨烟雾病(MMD)患者血流动力学及血清中VEGF、MCP-1水平变化。方法选取2020年11月—2022年12月收治的50例MMD成年人为MMD组,将同一时间内进行体检的50名健康人为健康组,检测两组VEGF、MCP-1水平及血流动力学。结果MMD组患者血清中VEGF、Ang-1和IL-8表达水平与健康组差异有统计学意义(P<0.05),血清MCP-1水平在MMD组和健康组中比较差异无统计学意义(P>0.05);不同铃木分期MMD患者血清中VEGF、Ang-1、IL-8和MCP-1表达水平差异无统计学意义(P>0.05);缺血和出血型MMD患者VEGF、Ang-1、IL-8和MCP-1表达水平差异无统计学意义(P>0.05);MMD组与健康组脑部流量、容量、通过时间及峰值时间差异均有统计学意义(P<0.05);3-6期MMD患者在rCBF、rCBV差异无统计学意义(P>0.05),MTT、TTP指标随着分期越高数值越大。结论MMD患者血清中VEGF水平与健康人群存在差异,MCP-1水平变化差异无统计学意义,MMD患者与健康人群脑部血流动力学存在差异。 Objective To investigate the changes of hemodynamics and serum VEGF and MCP-1 levels in patients with moyamoya disease(MMD).Methods From November 2020 to December 2022,50 MMD adults were selected into the MMD group.The 50 healthy people undergoing physical examination at the same time were selected as the healthy group,VEGF and MCP-1 levels and hemodynamics were detected in two groups.Results The expression levels of serum VEGF,Ang-1 and IL-8 in the MMD group were significantly different from those in the healthy group(P<0.05).The levels of serum MCP-1 were not significant in the MMD group and the healthy group(P>0.05).The expression levels of VEGF,Ang-1,IL-8 and MCP-1 in the serum of patients with different stages of Suzuki MMD had no significance(P>0.05).The expression levels of VEGF,Ang-1,IL-8 and MCP-1 in patients with ischemic and hemorrhagic MMD were not significant(P>0.05),and there were significant differences in brain flow,volume,transit time,and peak time between the MMD group and the healthy group(P<0.05).There was no significance in rCBF and rCBV in patients with stage 3-6 MMD(P>0.05),and the MTT and TTP indexes increased with the stage.Conclusion The levels of VEGF in serum of MMD patients are different from those of healthy people,and the changes of MCP-1 levels are not significant.There is a difference in cerebral hemodynamics between MMD patients and healthy people.
作者 高腾 苗亚秋 张小盼 GAO Teng;MIAO Ya-qiu;ZHANG Xiao-pan(Department of Neurosurgery,Shangqiu No.1 People's Hospital,Shangqiu,Henan,476000,China)
出处 《中国血液流变学杂志》 CAS 2023年第2期246-250,共5页 Chinese Journal of Hemorheology
关键词 烟雾病 VEGF MCP-1 血流动力学 MMD VEGF MCP-1 hemodynamics
  • 相关文献

参考文献19

二级参考文献160

  • 1赵明光,陈游力,宋振全,高永中,浦佩玉,魏学忠.血管生成因子在脑动静脉血管畸形发生发展过程中的生物学效应[J].中国临床康复,2006,10(6):73-75. 被引量:6
  • 2卢洁,李坤成,张苗,李鹏雨,冀瑞俊,宋阳,马新.64层螺旋CT脑灌注联合CT血管造影在短暂性脑缺血发作的应用[J].中华老年心脑血管病杂志,2006,8(12):806-809. 被引量:12
  • 3杨冀萍,刘新峰,刘怀军,徐格林.VEGF治疗脑缺血再灌注损伤的分子机制研究[J].中风与神经疾病杂志,2007,24(2):167-168. 被引量:4
  • 4Suzuki J.Takaku A.Cerebrovaseula "moyamoya" disease.Disease showing abnormal net-like vessels in base of brain[J].Archeurol,1969,20:288-299.
  • 5Kimura R,Nakase H,Tamaki R,et al.Vascular endothelial growth factor antagonist reduces brain edema formation and venous infarction[J].Stroke,2005,36:1259-1263.
  • 6Fukui M.Members of the research committee on spontaneous occlusion of the circle of Willis(Moyamoya'disease)of the Ministry of Health and Welfare,Japan.Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis (Moyamoya'disease)[J].Clin Neurol Neurosurg,1997,99(Suppl 2):238-240.
  • 7Ogawa K,Nagahiro S,Arakaki R,et al.Anti-a-fodrin auto anti-bodies in moyamoya disease[J].Stroke,2003,34(12):E244-246.
  • 8Takekawa Y,Umezawa T,Ueno Y,et al.Pathological and immunohistochemical findings of an autopsy case of adult moyamoya disease[J].Neuropathology,2004,24(3):236-242.
  • 9Nishikawa R,ChengSY,Nagashima R,et al.Expression of vaseular endothelial growth factor in human brain tumor[J].Aeta NeuroPathol,1998,96:453-462.
  • 10Yan C,Davis G.Vascular-specific-growth factor and blood vessl formation[J].Nature,2000,407(6801):242-248.

共引文献89

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部